N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline

C126H158N30O8S2 — CID 160954482

IUPACN-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline
SMILESCCc1nc(-c2cccc(NC)c2)no1.CNC(=O)c1cccc(NC)c1.CNC(=O)c1cccc(NC)c1.CNc1cccc(-c2ccn[nH]2)c1.CNc1cccc(-c2cscn2)c1.CNc1cccc(-c2cscn2)c1.CNc1cccc(-c2noc(NC)n2)c1.CNc1cccc(C(=O)N(C)C(C)C)c1.CNc1cccc(C(=O)NC2CCC2)c1.CNc1cccc(C(=O)NCC(C)C)c1.CNc1cccc(C(=O)NCC2CC2)c1.CNc1cccc(C2N=CN=N2)c1
InChIInChI=1S/2C12H16N2O.2C12H18N2O.C11H13N3O.C10H12N4O.C10H11N3.2C10H10N2S.C9H10N4.2C9H12N2O/c1-13-11-7-2-4-9(8-11)12(15)14-10-5-3-6-10;1-13-11-4-2-3-10(7-11)12(15)14-8-9-5-6-9;1-9(2)14(4)12(15)10-6-5-7-11(8-10)13-3;1-9(2)8-14-12(15)10-5-4-6-11(7-10)13-3;1-3-10-13-11(14-15-10)8-5-4-6-9(7-8)12-2;1-11-8-5-3-4-7(6-8)9-13-10(12-2)15-14-9;1-11-9-4-2-3-8(7-9)10-5-6-12-13-10;2*1-11-9-4-2-3-8(5-9)10-6-13-7-12-10;1-10-8-4-2-3-7(5-8)9-11-6-12-13-9;2*1-10-8-5-3-4-7(6-8)9(12)11-2/h2,4,7-8,10,13H,3,5-6H2,1H3,(H,14,15);2-4,7,9,13H,5-6,8H2,1H3,(H,14,15);5-9,13H,1-4H3;4-7,9,13H,8H2,1-3H3,(H,14,15);4-7,12H,3H2,1-2H3;3-6,11H,1-2H3,(H,12,13,14);2-7,11H,1H3,(H,12,13);2*2-7,11H,1H3;2-6,9-10H,1H3;2*3-6,10H,1-2H3,(H,11,12)
InChIKeySWEXDYRNMXHQLC-UHFFFAOYSA-N
MW2284.99 g/mol
LogP24.58
Rot. Bonds32

About N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline

N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline (PubChem CID 160954482) has the molecular formula C126H158N30O8S2 and a molecular weight of 2284.99 g/mol. Its IUPAC name is N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline.

Molecular Properties

Compound NameN-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline
PubChem CID160954482
Molecular FormulaC126H158N30O8S2
Molecular Weight2284.99 g/mol
Exact Mass2283.23
IUPAC NameN-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline
SMILESCCc1nc(-c2cccc(NC)c2)no1.CNC(=O)c1cccc(NC)c1.CNC(=O)c1cccc(NC)c1.CNc1cccc(-c2ccn[nH]2)c1.CNc1cccc(-c2cscn2)c1.CNc1cccc(-c2cscn2)c1.CNc1cccc(-c2noc(NC)n2)c1.CNc1cccc(C(=O)N(C)C(C)C)c1.CNc1cccc(C(=O)NC2CCC2)c1.CNc1cccc(C(=O)NCC(C)C)c1.CNc1cccc(C(=O)NCC2CC2)c1.CNc1cccc(C2N=CN=N2)c1
InChIInChI=1S/2C12H16N2O.2C12H18N2O.C11H13N3O.C10H12N4O.C10H11N3.2C10H10N2S.C9H10N4.2C9H12N2O/c1-13-11-7-2-4-9(8-11)12(15)14-10-5-3-6-10;1-13-11-4-2-3-10(7-11)12(15)14-8-9-5-6-9;1-9(2)14(4)12(15)10-6-5-7-11(8-10)13-3;1-9(2)8-14-12(15)10-5-4-6-11(7-10)13-3;1-3-10-13-11(14-15-10)8-5-4-6-9(7-8)12-2;1-11-8-5-3-4-7(6-8)9-13-10(12-2)15-14-9;1-11-9-4-2-3-8(7-9)10-5-6-12-13-10;2*1-11-9-4-2-3-8(5-9)10-6-13-7-12-10;1-10-8-4-2-3-7(5-8)9-11-6-12-13-9;2*1-10-8-5-3-4-7(6-8)9(12)11-2/h2,4,7-8,10,13H,3,5-6H2,1H3,(H,14,15);2-4,7,9,13H,5-6,8H2,1H3,(H,14,15);5-9,13H,1-4H3;4-7,9,13H,8H2,1-3H3,(H,14,15);4-7,12H,3H2,1-2H3;3-6,11H,1-2H3,(H,12,13,14);2-7,11H,1H3,(H,12,13);2*2-7,11H,1H3;2-6,9-10H,1H3;2*3-6,10H,1-2H3,(H,11,12)
InChIKeySWEXDYRNMXHQLC-UHFFFAOYSA-N
XLogP24.58
TPSA491.58 Ų
H-Bond Donors19
H-Bond Acceptors33
Rotatable Bonds32
Heavy Atoms166
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002284.99
LogP ≤ 524.58
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1033

Analyze N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline?
The IUPAC name of N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline (CID 160954482) is N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline.
What is the SMILES notation for N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline?
The canonical SMILES for N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline is CCc1nc(-c2cccc(NC)c2)no1.CNC(=O)c1cccc(NC)c1.CNC(=O)c1cccc(NC)c1.CNc1cccc(-c2ccn[nH]2)c1.CNc1cccc(-c2cscn2)c1.CNc1cccc(-c2cscn2)c1.CNc1cccc(-c2noc(NC)n2)c1.CNc1cccc(C(=O)N(C)C(C)C)c1.CNc1cccc(C(=O)NC2CCC2)c1.CNc1cccc(C(=O)NCC(C)C)c1.CNc1cccc(C(=O)NCC2CC2)c1.CNc1cccc(C2N=CN=N2)c1.
What is the InChIKey of N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline?
The InChIKey is SWEXDYRNMXHQLC-UHFFFAOYSA-N. The full InChI is InChI=1S/2C12H16N2O.2C12H18N2O.C11H13N3O.C10H12N4O.C10H11N3.2C10H10N2S.C9H10N4.2C9H12N2O/c1-13-11-7-2-4-9(8-11)12(15)14-10-5-3-6-10;1-13-11-4-2-3-10(7-11)12(15)14-8-9-5-6-9;1-9(2)14(4)12(15)10-6-5-7-11(8-10)13-3;1-9(2)8-14-12(15)10-5-4-6-11(7-10)13-3;1-3-10-13-11(14-15-10)8-5-4-6-9(7-8)12-2;1-11-8-5-3-4-7(6-8)9-13-10(12-2)15-14-9;1-11-9-4-2-3-8(7-9)10-5-6-12-13-10;2*1-11-9-4-2-3-8(5-9)10-6-13-7-12-10;1-10-8-4-2-3-7(5-8)9-11-6-12-13-9;2*1-10-8-5-3-4-7(6-8)9(12)11-2/h2,4,7-8,10,13H,3,5-6H2,1H3,(H,14,15);2-4,7,9,13H,5-6,8H2,1H3,(H,14,15);5-9,13H,1-4H3;4-7,9,13H,8H2,1-3H3,(H,14,15);4-7,12H,3H2,1-2H3;3-6,11H,1-2H3,(H,12,13,14);2-7,11H,1H3,(H,12,13);2*2-7,11H,1H3;2-6,9-10H,1H3;2*3-6,10H,1-2H3,(H,11,12).
What are the key properties of N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline?
N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline has a molecular weight of 2284.99 g/mol, XLogP of 24.58, 32 rotatable bonds, 19 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclobutyl-3-(methylamino)benzamide;N-(cyclopropylmethyl)-3-(methylamino)benzamide;3-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylaniline;3-(methylamino)-N-(2-methylpropyl)benzamide;bis(N-methyl-3-(methylamino)benzamide);N-methyl-3-[3-(methylamino)phenyl]-1,2,4-oxadiazol-5-amine;N-methyl-3-(methylamino)-N-propan-2-ylbenzamide;N-methyl-3-(1H-pyrazol-5-yl)aniline;bis(N-methyl-3-(1,3-thiazol-4-yl)aniline);N-methyl-3-(3H-1,2,4-triazol-3-yl)aniline is sourced from PubChem (CID 160954482), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).